Dr. George Mammen is currently a post-doctoral fellow at Toronto’s Centre for Addiction and Mental Health. His focus of research revolves around cannabis’ medical application, particularly in mood and anxiety disorders, along with the public health implications of upcoming legalization. George is also a consultant for Beleave Inc., where he is contributing to a number of health research and education projects around medical cannabis (e.g., preparing to collect patient-data to study medical cannabis’ long-term effects on various conditions) and recreational cannabis (e.g., synthesizing scientific content for an educational campaign around cannabis impaired driving).
